Literature DB >> 11683989

New frontiers in Alzheimer's disease genetics.

R E Tanzi1, L Bertram.   

Abstract

Alzheimer's disease (AD) is a genetically complex disorder that accounts for the majority of dementia in the elderly population. Over 100 rare, highly penetrant mutations have been described in three genes (APP, PSEN1, PSEN2) for early-onset familial AD. In the more common late-onset form, a polymorphism in the apolipoprotein E gene has been associated with increased susceptibility. However, recent studies suggest that these four genes account for less than 30% of the genetic variance for AD and that more genetic factors remain to be identified. In this review, we present a brief history of AD genetics and preview some of the next frontiers in Alzheimer gene discovery primarily focusing on chromosomes 12, 10, and 9.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683989     DOI: 10.1016/s0896-6273(01)00476-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  115 in total

Review 1.  Searching for the mountains of the moon: genome scans for atherosclerosis.

Authors:  Michael A Province
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

2.  Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate.

Authors:  Roel A Ophoff; Michael A Escamilla; Susan K Service; Mitzi Spesny; Dar B Meshi; Wingman Poon; Julio Molina; Eduardo Fournier; Alvaro Gallegos; Carol Mathews; Thomas Neylan; Steven L Batki; Erin Roche; Margarita Ramirez; Sandra Silva; Melissa C De Mille; Penny Dong; Pedro E Leon; Victor I Reus; Lodewijk A Sandkuijl; Nelson B Freimer
Journal:  Am J Hum Genet       Date:  2002-07-15       Impact factor: 11.025

Review 3.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

4.  Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide.

Authors:  Kirk J Pak; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

5.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 6.  Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

Authors:  Dennis W Dickson
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 7.  Immunization treatment approaches in Alzheimer's and prion diseases.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition.

Authors:  Eric H Chang; Attilio Rigotti; Patricio T Huerta
Journal:  Neurobiol Aging       Date:  2007-08-23       Impact factor: 4.673

Review 10.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.